Prostate cancer trials in Netherlands

In Netherlands 69 Also abroad 1481

69 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Where
Amsterdam, Maastricht
Age
18 years and over
People
52 worldwide
Run by
AstraZeneca
See details and how to joinNCT07192614 · EU 2025-520626-37-00
No phaseTaking people
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Where
Amsterdam
Age
18 years and over
People
27
Run by
Amsterdam UMC, location VUmc
See details and how to joinNCT07782164
Phase 3Not yet taking people in Netherlands
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
Where
Amsterdam-Zuidoost
Age
18 years and over
People
300 worldwide
Run by
Thomas Jefferson University
See details and how to joinNCT06024772
Phase 1Taking people
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Where
Groningen, Rotterdam
Age
18 years and over
People
198 worldwide
Run by
Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00
Phase 4Taking people
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Where
Delft, Maastricht, Nijmegen
Age
18 years to 100 years
People
700 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00
Phase 4Not yet taking people in Netherlands
Comparison of standard abiraterone dosing and dosing based on abiraterone blood levels
Where
Amsterdam
Age
18 years and over
People
230
Run by
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2025-524440-35-00 · EU 2025-524440-35-00
No phaseTaking people
High-Risk prostatE Cancer radiatiOn Versus surgERy
Where
Alkmaar, Amsterdam, Assen, Beverwijk, Dordrecht, Eindhoven, Goes, Groningen, Hardenberg, Harderwijk, Hoofddorp, Hoogeveen, Hoorn, Leiden, Nijmegen, Rotterdam, Scheemda, The Hague, Tilburg, Veldhoven, Zaandam
Age
50 years to 75 years
People
837
Run by
Comprehensive Cancer Centre The Netherlands
See details and how to joinNCT05931419
Phase 1/2Taking people
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Where
Amersfoort, Nijmegen
Age
18 years and over
People
82 worldwide
Run by
Blue Earth Therapeutics Ltd
See details and how to joinNCT05413850 · EU 2024-511537-35-00
Phase 3Taking people
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
Where
Beugen, Dordrecht, Nijmegen
Age
18 years and over
People
300 worldwide
Run by
UNICANCER
See details and how to joinNCT04916613 · EU 2022-502425-18-00
No phaseTaking people
Lab Research Using Mini-tumors to Study Prostate Cancer Treatments
Where
Heerlen, Maastricht
Age
18 years and over
People
600
Run by
Maastricht Radiation Oncology
See details and how to joinNCT07004582
Phase 1/2Not yet taking people in Netherlands
Clinical Application of the Androgen Receptor Inhibitor Darolutamide to Upregulate the Prostate-Specific Membrane Antigen (PSMA) Protein Expression in Patients with Hormone Sensitive Prostate Cancer. - The DARO-flare Trial -
Where
Amsterdam
Age
18 years and over
People
32
Run by
Amsterdam UMC Stichting
See details and how to join2025-520482-52-03 · EU 2025-520482-52-03
Phase 2Taking people
DAROTAXEL
Where
Almelo, Amsterdam, Apeldoorn, Deventer, Dordrecht, Drachten, Geleen, Goes, Leeuwarden, Nijmegen, Roosendaal, Rotterdam, Schiedam, 's-Gravenhage, 'S-Hertogenbosch, Utrecht, Zwolle
Age
18 years and over
People
245
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-516939-28-00 · EU 2024-516939-28-00
No phaseTaking people
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Where
Amsterdam, Deventer, Leeuwarden, Nijmegen, Utrecht
Age
18 years and over
People
8,000 worldwide
Run by
UMC Utrecht
See details and how to joinNCT04075305
No phaseTaking people
Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation
Where
Nieuwegein, Utrecht
Age
18 years and over
People
1,500
Run by
UMC Utrecht
See details and how to joinNCT04228211
No phaseTaking people
EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT)
Where
Utrecht
Age
18 years and over
People
70
Run by
UMC Utrecht
See details and how to joinNCT04861194
No phaseTaking people
Detection of Minimal Residual Disease Post-prostatectomy
Where
Nijmegen
Age
18 years and over
People
50
Run by
Radboud University Medical Center
See details and how to joinNCT07334275
No phaseTaking people
Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer
Where
Amsterdam, Arnhem, Emmen, Nieuwegein, Nijmegen, Rotterdam
Age
18 years and over
People
503
Run by
St. Antonius Hospital
See details and how to joinNCT07180381
Phase 3Taking people
Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-volume castration-sensitive prostate cancer: a randomized Nationwide Study
Where
Alkmaar, Almelo, Amersfoort, Amsterdam, Assen, Beverwijk, Deventer, Eindhoven, Emmen, Enschede, Goes, Groningen, Haarlem, Hilversum, Leeuwarden, Maastricht, Nieuwegein, Nijmegen, Roermond, Roosendaal, Rotterdam, 's-Gravenhage, 'S-Gravenhage, Venlo
Age
18 years and over
People
400
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-506698-36-00 · EU 2023-506698-36-00
Phase 3Taking people
Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer
Where
Alkmaar, Amersfoort, Amsterdam, Assen, Beverwijk, Deventer, Eindhoven, Emmen, Enschede, Goes, Groningen, Haarlem, Hengelo, Hilversum, Leeuwarden, Maastricht, Nijmegen, Roermond, Roosendaal, Rotterdam, The Hague, Utrecht, Venlo
Age
18 years and over
People
400
Run by
Nick Beije
See details and how to joinNCT07260435
Phase 1/2Taking people
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Where
Maastricht, Rotterdam
Age
18 years and over
People
126 worldwide
Run by
Maastricht University Medical Center
See details and how to joinNCT04954599
No phaseTaking people
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
Where
Deventer, Nijmegen
People
302 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06462963
No phaseTaking people
Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
Where
Amsterdam
Age
18 years and over
People
100
Run by
The Netherlands Cancer Institute
See details and how to joinNCT06691776
Phase 1/2Not yet taking people in Netherlands
DUAL
Where
Amsterdam
Age
18 years and over
People
13
Run by
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2023-505453-40-00 · EU 2023-505453-40-00
No phaseTaking people
The Radium-select Study
Where
Amersfoort, Amsterdam, Nieuwegein, Utrecht
Age
18 years and over
People
60
Run by
The Netherlands Cancer Institute
See details and how to joinNCT06659926
Phase 1Taking people
Phase I study of 225Ac-PSMA I&T in prostate cancer
Where
Rotterdam
Age
18 years and over
People
30
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-513729-22-01 · EU 2024-513729-22-01